NO933809L - Fremgangsm}te for fremstilling av (1S-(1R*,2S*,3R*))-N-(4-morfolinylsulfonyl)-L-fenylalanyl-3-(2-amino-4-tiazolyl)-N-((1-cykloheksylmetyl)-2,3-dihydroksy-5-metylheksyl)-L-alaninamid - Google Patents

Fremgangsm}te for fremstilling av (1S-(1R*,2S*,3R*))-N-(4-morfolinylsulfonyl)-L-fenylalanyl-3-(2-amino-4-tiazolyl)-N-((1-cykloheksylmetyl)-2,3-dihydroksy-5-metylheksyl)-L-alaninamid

Info

Publication number
NO933809L
NO933809L NO933809A NO933809A NO933809L NO 933809 L NO933809 L NO 933809L NO 933809 A NO933809 A NO 933809A NO 933809 A NO933809 A NO 933809A NO 933809 L NO933809 L NO 933809L
Authority
NO
Norway
Prior art keywords
morpholinylsulfonyl
alaninamide
phenylalanyl
methylhexyl
cyclohexylmethyl
Prior art date
Application number
NO933809A
Other languages
English (en)
Other versions
NO309479B1 (no
Inventor
Daniel Thomas Belmont
Valerie Hendrickson
John Mark Hoekman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO933809L publication Critical patent/NO933809L/no
Publication of NO309479B1 publication Critical patent/NO309479B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO933809A 1991-04-23 1993-10-22 Fremgangsmåte for fremstilling av (1S-(1R*,2S*,3R*))-N-(4- morfolinylsulfonyl)-L-fenylalanyl-3-(2-amino-4-tiazolyl)-N-((1- cykloheksylmetyl)-2,3-dihydroksy-5-metylheksyl)-L-alaninamid NO309479B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/690,012 US5089616A (en) 1991-04-23 1991-04-23 Process for the preparation of [1S-(1R*,2S*,3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl-N-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide
PCT/US1992/003146 WO1992018486A1 (en) 1991-04-23 1992-04-15 Improved process for the preparation of [1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide

Publications (2)

Publication Number Publication Date
NO933809L true NO933809L (no) 1993-10-22
NO309479B1 NO309479B1 (no) 2001-02-05

Family

ID=24770744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933809A NO309479B1 (no) 1991-04-23 1993-10-22 Fremgangsmåte for fremstilling av (1S-(1R*,2S*,3R*))-N-(4- morfolinylsulfonyl)-L-fenylalanyl-3-(2-amino-4-tiazolyl)-N-((1- cykloheksylmetyl)-2,3-dihydroksy-5-metylheksyl)-L-alaninamid

Country Status (12)

Country Link
US (1) US5089616A (no)
EP (1) EP0581899A4 (no)
JP (1) JP3247696B2 (no)
KR (2) KR100221767B1 (no)
AU (1) AU653851B2 (no)
CA (1) CA2106673A1 (no)
FI (1) FI106030B (no)
IE (1) IE921288A1 (no)
MX (1) MX9201831A (no)
NO (1) NO309479B1 (no)
PT (1) PT100425B (no)
WO (1) WO1992018486A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
US5275950A (en) * 1990-05-11 1994-01-04 Abbott Laboratories Process for the preparation of a renin inhibiting compound
US5223615A (en) * 1990-06-28 1993-06-29 Shionogi & Co., Ltd. Dipeptide derivatives
US6376506B1 (en) 1997-01-23 2002-04-23 Syntex (U.S.A.) Llc Sulfamide-metalloprotease inhibitors
ZA98376B (en) * 1997-01-23 1998-07-23 Hoffmann La Roche Sulfamide-metalloprotease inhibitors
US6130220A (en) * 1997-10-16 2000-10-10 Syntex (Usa) Inc. Sulfamide-metalloprotease inhibitors
WO2010143409A1 (ja) * 2009-06-08 2010-12-16 株式会社カネカ 光学活性チアゾリルアラニン誘導体およびその塩の製造方法
CA3143132A1 (en) * 2019-06-11 2020-12-17 Fortephest Ltd. Novel non-coding heterocyclic amino acids (nchaa) and their use as herbicides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US4238923A (en) * 1979-06-22 1980-12-16 Combustion Engineering, Inc. Method of low temperature heat utilization for atmospheric pressure coal gasification
JPH071427B2 (ja) * 1989-05-26 1995-01-11 株式会社日立製作所 トレンドグラフ表示方式
US5238923A (en) * 1989-05-26 1993-08-24 Warner-Lambert Company Amino-substituted heterocycles as renin inhibitors

Also Published As

Publication number Publication date
IE921288A1 (en) 1992-11-04
AU2183592A (en) 1992-11-17
JP3247696B2 (ja) 2002-01-21
US5089616A (en) 1992-02-18
CA2106673A1 (en) 1992-10-29
NO309479B1 (no) 2001-02-05
AU653851B2 (en) 1994-10-13
KR100221767B1 (ko) 1999-09-15
KR100317147B1 (ko) 2001-12-22
WO1992018486A1 (en) 1992-10-29
EP0581899A1 (en) 1994-02-09
FI934594A (fi) 1993-10-18
FI934594A0 (fi) 1993-10-18
MX9201831A (es) 1992-10-01
FI106030B (fi) 2000-11-15
PT100425A (pt) 1993-08-31
EP0581899A4 (en) 1996-10-02
JPH06507406A (ja) 1994-08-25
PT100425B (pt) 1999-10-29

Similar Documents

Publication Publication Date Title
PT90035A (pt) Processo para a preparacao de uma pastilha de limpeza de dentaduras
BR8901037A (pt) Compostos,mistura sensivel a luz e processo para a preparacao de um composto
FI894637A0 (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
AU3707889A (en) Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
NO881164L (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
DE3483899D1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate.
NO883054D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
FI891227A (fi) Katekolderivat och farmaceutiska preparat som innehaoller dessa.
IT7825474A0 (it) 1-acil-2-cian-aziridine, processo per la loro preparazione e preparati farmaceutici contenenti tali composti.
NO933809L (no) Fremgangsm}te for fremstilling av (1S-(1R*,2S*,3R*))-N-(4-morfolinylsulfonyl)-L-fenylalanyl-3-(2-amino-4-tiazolyl)-N-((1-cykloheksylmetyl)-2,3-dihydroksy-5-metylheksyl)-L-alaninamid
PT89570A (pt) Processo para a preparacao de novos compostos de 1,3-dicarbonilo ciclicos
NO901232D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
BR9205413A (pt) Processo para a preparação de (S)-cianoidrinas oticamente ativas.
BR8901036A (pt) Compostos,processo para sua preparacao,bem como sua aplicacao
BR9600370A (pt) Benzenossulfoniluréias e-tiouréias substituídas processo para a sua preparação seus usos e medicamento contendo as mesmas
FI950874A (fi) Uudet polyjoditetut yhdisteet, menetelmä niiden valmistamiseksi, niitä sisältävä varjoaine
NO890096L (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
DE3481418D1 (de) Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
IT8722452A0 (it) Processo per la sintesi di una n ndialchil idrossilammina.
NO924891D0 (no) Fremgangsmaate for fremstilling av et frittstroemmende, pulverformig, toeymyknende preparat
IT8448789A0 (it) Composti amminometilici, procedimento per produrli, preparati farmaceutici che li contengono
FI873566A0 (fi) Farmaceutiska preparat som absorberas genom huden och foerfarande foer framstaellning av dem.
DK256689A (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
DK222888A (da) Anellerede heteroalkylenquinolinaminer, isomere og salte deraf, deres fremstilling og anvendelse som laegemidler smat mellemprodukter til fremstillingen
KR950703559A (ko) 신규한 축합 티아졸 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물(Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees